Primary Site >> Biliary tract Cancer
Gene >> DCK
|
|
|
|
|
|---|---|---|---|---|
|
Ref: DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells. PMID: 22490663 Ref: Establishment and characterization of a new human gallbladder carcinoma cell line. PMID: 22843894 |
Ref: Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone. PMID: 23710668 Ref: Clinicopathological significance of deoxycytidine kinase expression in esophageal squamous cell carcinoma. PMID: 24649234 |
Ref: Cholangiocarcinoma cell line TK may be useful for the pharmacokinetic study of the chemotherapeutic agent gemcitabine. PMID: 24891233 |
Ref: Acquisition of chemoresistance to gemcitabine is induced by a loss-of-function missense mutation of DCK. PMID: 26196746 Ref: Cytidine Deaminase as a Molecular Predictor of Gemcitabine Response in Patients with Biliary Tract Cancer. PMID: 26418006 |
Ref: DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study. PMID: 29113399 |